Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study

BACKGROUND: Anti-thymoglobulin (ATG)-based immunosuppressive treatment (IST) is the standard first-line management for patients with severe AA/very severe AA (SAA/VSAA) and is not suitable for allogeneic stem cell transplantation. The response predictor was not fully investigated. OBJECTIVE: The pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qi, Dong, Huijie, Li, Yuzhu, Shen, Yingying, Hong, Yilei, Chen, Ying, Liu, Shan, Wu, Xiaolian, Liu, Wenbin, Hu, Huijin, Zhao, Yuechao, Lin, Shenyun, Shen, Yiping, Zhou, Yuhong, Ye, Baodong, Wu, Dijiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531379/
https://www.ncbi.nlm.nih.gov/pubmed/36192750
http://dx.doi.org/10.1186/s12944-022-01703-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531379/
https://www.ncbi.nlm.nih.gov/pubmed/36192750
http://dx.doi.org/10.1186/s12944-022-01703-0

Ejemplares similares